Sumitomo Mitsui Trust Group, Inc. - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 249 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sumitomo Mitsui Trust Group, Inc. ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q2 2024$24,976,664
+26.0%
6,899,631
+11.7%
0.02%
+28.6%
Q1 2024$19,827,229
-37.9%
6,176,707
-5.1%
0.01%
-41.7%
Q4 2023$31,907,129
-10.9%
6,511,659
-0.9%
0.02%
-17.2%
Q3 2023$35,811,618
-16.4%
6,570,939
+2.9%
0.03%
-12.1%
Q2 2023$42,836,955
-8.9%
6,384,047
+19.9%
0.03%
-5.7%
Q1 2023$46,997,993
+14.9%
5,322,536
-0.6%
0.04%
+9.4%
Q4 2022$40,891,687
+18.7%
5,352,315
+10.6%
0.03%
+14.3%
Q3 2022$34,448,000
-7.8%
4,838,191
+4.8%
0.03%
-3.4%
Q2 2022$37,363,000
-34.9%
4,618,399
+11.8%
0.03%
-23.7%
Q1 2022$57,353,000
-36.0%
4,132,060
+29.3%
0.04%
-30.9%
Q4 2021$89,664,000
+27.9%
3,195,446
+55.0%
0.06%
+25.0%
Q3 2021$70,087,000
-6.0%
2,062,001
+13.1%
0.04%0.0%
Q2 2021$74,526,000
+331.4%
1,823,941
+325.1%
0.04%
+300.0%
Q1 2021$17,276,000
+21.2%
429,103
+77.9%
0.01%
+22.2%
Q4 2020$14,259,000
+38.3%
241,147
+13.7%
0.01%
+28.6%
Q3 2020$10,313,000
+11.5%
212,063
+11.0%
0.01%0.0%
Q2 2020$9,246,000
+1441.0%
191,117
+784.8%
0.01%
+600.0%
Q1 2020$600,00021,6000.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2021
NameSharesValueWeighting ↓
Rubric Capital Management LP 14,000,000$50,680,0001.33%
Tejara Capital Ltd 909,061$3,290,8011.20%
Pier Capital, LLC 1,055,299$3,820,1820.57%
Soleus Capital Management, L.P. 1,720,000$6,226,4000.55%
ESSEX INVESTMENT MANAGEMENT CO LLC 623,825$2,258,2470.42%
VIKING GLOBAL INVESTORS LP 29,993,708$108,577,2230.42%
ARK Investment Management 11,412,000$41,311,4400.37%
Aristotle Atlantic Partners, LLC 2,974,188$10,766,5610.35%
DDD Partners, LLC 769,997$2,787,3890.32%
Matrix Capital Management Company, LP 11,572,590$41,892,7760.32%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders